It could be of interest to us.
Roche seems to be investing in a new form of Rituximab, a jab rather than an infusion. Potentially with a new patent.
http://www.dailymail.co.uk/health/a...-blood-cancer-patients.html?ito=feeds-newsxml
This could mean that they may want to expand the list of pathologies to ME and therefore fund some trials.
Tito
Roche seems to be investing in a new form of Rituximab, a jab rather than an infusion. Potentially with a new patent.
http://www.dailymail.co.uk/health/a...-blood-cancer-patients.html?ito=feeds-newsxml
This could mean that they may want to expand the list of pathologies to ME and therefore fund some trials.
Tito